Target intelligence / Profile preview

Vasomotor center (VMC)

Target
VMC
Molecular classification
Other (Neural Network), Anatomical Brain Region
01

Overview

The vasomotor center is a functional collection of neurons located in the medulla oblongata of the brainstem that serves as the primary integrator for cardiovascular homeostasis (StatPearls, 2023). It regulates blood pressure and heart rate by modulating the activity of the sympathetic nervous system in response to inputs from baroreceptors, chemoreceptors, and higher brain centers (NIH, 2022). The center is composed of several sub-regions, most notably the rostral ventrolateral medulla (RVLM), which maintains tonic sympathetic tone, and the nucleus tractus solitarius (NTS), which processes afferent sensory information (Wikipedia, 2024). In conditions such as essential hypertension and heart failure, the vasomotor center often exhibits pathological overactivity, contributing to increased systemic vascular resistance (PubMed, 2021). While not a single molecular target, it is the site of action for centrally acting antihypertensive drugs like clonidine and methyldopa, which stimulate alpha-2 adrenergic receptors to inhibit sympathetic outflow (PubChem, 2024). Consequently, pharmacological modulation of this center is an established strategy for managing refractory hypertension, though it is associated with central nervous system side effects like sedation (StatPearls, 2023).

Other names
Medullary vasomotor centerCardiovascular centerVasomotor areaBulbar vasomotor center
02

Mechanism of action

Activation of alpha-2 adrenergic receptors and imidazoline I1 receptors within the medulla oblongata, which inhibits the tonic excitatory drive to sympathetic preganglionic neurons, thereby reducing peripheral vascular resistance and heart rate (StatPearls, 2023; PubChem, 2024).

03

Biological functions

Blood pressure regulation (StatPearls, 2023)Sympathetic nervous system modulation (NIH, 2022)Heart rate control (StatPearls, 2023)Baroreflex integration (Wikipedia, 2024)Peripheral resistance regulation (StatPearls, 2023)
04

Disease associations

Hypertension (StatPearls, 2023)Heart failure (PubMed, 2022)Autonomic dysfunction (NIH, 2022)Orthostatic hypotension (Wikipedia, 2024)
05

Safety considerations

Sedation (StatPearls, 2023)Xerostomia (NIH, 2023)Bradycardia (PubChem, 2024)Rebound hypertension (StatPearls, 2023)Depression (NIH, 2023)
06

Interacting drugs

Clonidine (PubChem, 2024)

4 more in the full profile.

07

Biomarkers

Blood pressure (StatPearls, 2023)Heart rate (StatPearls, 2023)Plasma norepinephrine (PubMed, 2021)Muscle sympathetic nerve activity (MSNA) (PubMed, 2021)

Beyond the preview

Go deeper on Vasomotor center (VMC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vasomotor center (VMC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call